Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Tenofovir disoproxil fumarate and entecavir differ in their association with the risk of hepatocellular carcinoma. Treatment should be guided by patient tolerability and affordability rather than whether one drug is more effective than the other.
